Nordic Coronary and Peripheral Stents Market Outlook (2022-2033)

The Nordic coronary and peripheral stents market size is expected to reach US$ 354.9 million by 2033 from US$ 161.8 million in 2024. The market is estimated to record a CAGR of 9.1% from 2025 to 2033.

Executive Summary and Nordic Coronary and Peripheral Stents Market Analysis:

The Nordic coronary and peripheral stents market is mature and highly structured, supported by advanced healthcare systems and strong public-sector healthcare funding. The region experiences consistent demand for coronary and peripheral stents due to an aging population, high prevalence of cardiovascular diseases, and increasing awareness of minimally invasive interventions. Hospitals emphasize clinical outcomes, patient safety, and evidence-based procedures, which drives steady adoption of both coronary and peripheral stents. Market growth is, however, moderated by stringent health technology assessments, centralized procurement processes, and cost containment measures that influence adoption of premium-priced devices. Despite these restraints, ongoing investments in hospital infrastructure, interventional cardiology training programs, and integration of advanced procedural protocols support sustained procedural volumes. The Nordic region’s emphasis on high-quality care, combined with strong clinical governance, ensures a stable market environment for stent utilization while encouraging gradual adoption of innovative technologies under controlled regulatory frameworks.

Nordic Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contributed to the derivation of the coronary and peripheral stents market analysis are product type, material type, application and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Superior efficacy in reducing restenosis, longer-term patient outcomes, and widespread physician preference drove adoption, making them the most trusted choice compared to bare-metal or bioresorbable alternatives.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. High durability, proven biocompatibility, cost-effectiveness, and established clinical success ensured dominance, as polymer and hybrid options remain limited in availability, scalability, and long-term performance validation.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominated the market in 2024. Higher global prevalence, significant clinical burden, and greater demand for interventional procedures positioned coronary stents as the leading application, overshadowing peripheral artery disease interventions in overall market share.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Comprehensive infrastructure, advanced catheterization facilities, skilled specialists, and ability to handle complex cases ensured hospitals remained the primary setting for stent implantation, surpassing smaller clinics and ambulatory centers.   

Nordic Coronary and Peripheral Stents Market Outlook

The Nordic coronary and peripheral stents market is concentrated in specialized cardiac centers and tertiary-care hospitals, where coronary stenting accounts for the majority of interventions. Peripheral stents are increasingly utilized for complex vascular procedures, particularly in diabetic and elderly populations. A key driver of market growth is the integration of advanced diagnostic and interventional cardiology services within national healthcare systems. Early detection of vascular diseases and efficient referral pathways facilitate timely intervention, reducing reliance on open surgical procedures. Hospitals prioritize high-quality stent platforms with proven long-term outcomes, and participation in clinical registries reinforces evidence-driven adoption. Continuous professional development and inter-hospital collaboration further enhance procedural consistency, fostering stable demand for both coronary and peripheral stents across the region.

Nordic Coronary and Peripheral Stents Market Country Insights

Based on country, the Nordic coronary and peripheral stents market is further segmented into Sweden, Norway, Denmark, and Finland. Sweden held the largest share in 2024.

Sweden dominates the Nordic coronary and peripheral stents market due to its advanced healthcare system, strong regulatory oversight, and established interventional cardiology infrastructure. Swedish hospitals are well-equipped with modern catheterization laboratories and consistently follow national guidelines for coronary and peripheral interventions. Drug-eluting coronary stents are standard in most centers, while peripheral stents are gaining traction for advanced vascular complications in diabetic and aging patients. Centralized procurement, value-based purchasing, and participation in clinical registries influence device selection and maintain high-quality care standards. Sweden also invests heavily in physician training, research, and procedural standardization, ensuring high procedural volumes and consistent outcomes. Despite a controlled and cost-conscious market environment, Sweden’s scale, healthcare efficiency, and clinical expertise position it as the leading stents market in the Nordic region.

Nordic Coronary and Peripheral Stents Market Company Profiles

Medtronic, Boston Scientific Corporation, Abbott, B. Braun SE, TERUMO CORPORATION, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Cook Medical, Meril Life Sciences and Translumina are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

Nordic Coronary and Peripheral Stents Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Nordic Coronary and Peripheral Stents Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• European Society of Cardiology
• American College of Cardiology
• American Heart Association
• Asian Pacific Society of Interventional Cardiology
• Company website
• Company annual reports
• Company investor presentations